NDC11 31722057447
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 31722-0574-47 | 31722-0574 |
| 31722-574-47 | 31722-574 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 31722-574 | 31722-574-47 | E | Excluded after deficient or non-compliant submission was not corrected | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM ORAL | Camber Pharmaceuticals, Inc. | 0bc8468f-832c-4e71-95a2-db464d4d54bc | 2024-08-03 | Warnings, Adverse reactions | 31722-574-47 31722-574 31722057447 |